Sarolaner (CAS 1398609-39-6)
🌟 ChemicalBook Product Introduction
📌 Product Overview
Sarolaner (C₂₃H₁₈Cl₂F₄N₂O₅S), a broad-spectrum veterinary antiparasitic, is a potent GABA chloride channel inhibitor that rapidly eliminates ectoparasites like fleas, ticks, and mites. With a molecular weight of 581.36 g/mol, this white to off-white crystalline powder (≥99% purity, HPLC validated) is formulated for topical and oral use in companion animals. It combines high efficacy with minimal toxicity, making it ideal for pharmaceutical R&D and bulk API production.
Google Keywords: Sarolaner CAS 1398609-39-6, Veterinary Antiparasitic API Supplier, High-Purity Ectoparasiticide, Research Chemicals
✅ Key Advantages
🔹 Ultra-High Purity
≥99% purity (HPLC/UV validated) | Complies with EP/USP/CP standards.
🔹 Rapid Action & Stability
Kills parasites within 24 hours | Stable for 3 years under dry, light-protected storage.
🔹 GMP-Certified Production
Manufactured in ISO 9001 and GMP-compliant facilities.
🏥 Application Fields
Veterinary Medicine: Topical/oral treatments for dogs and cats.
Pharmaceutical R&D: Key intermediate for antiparasitic drug development.
Chemical Export: Bulk supply for global pharmaceutical manufacturing.
📜 Quality Certifications
Testing Methods: HPLC, NMR, MS, microbial limit testing.
Certifications: GMP, ISO 9001, REACH, and FDA-aligned protocols.
📊 Market Trends
The global veterinary antiparasitic market is projected to grow at 5.2% CAGR (2025-2030), driven by rising pet ownership and demand for non-toxic parasiticides. Asia-Pacific leads in API production, with Sarolaner emerging as a cost-effective solution for companion animal healthcare.
China
